Athenex, Inc. to Report Third Quarter 2020 Earnings Results on November 5, 2020

NEXT STORY
Global Home Healthcare Market (2020 to 2025) – Untapped Developing Regions Presents Opportunities
PREV STORY
MediciNova, in Collaboration with the University of Sydney and the Australasian Gastro-Intestinal Trials Group, Announces Plans for a Multi-center, Phase 2b Study to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer

Oslo, Norway, 11 October 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a ...

author_avatar
NASDAQ Market News

GigaGen Announces Publication of Research Describing a New Class of Drugs, Recombinant Hyperimmunes, Including its Novel COVID-19 Therapy, GIGA-2050

author_avatar
NASDAQ Market News

UroGen Pharma Announces Pricing of Initial Public Offering

RA’ANANA, Israel, May 03, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd., a clinical stage ...

author_avatar
NASDAQ Market News